291 related articles for article (PubMed ID: 17005406)
1. New multipotent tetracyclic tacrines with neuroprotective activity.
Marco-Contelles J; León R; de los Ríos C; García AG; López MG; Villarroya M
Bioorg Med Chem; 2006 Dec; 14(24):8176-85. PubMed ID: 17005406
[TBL] [Abstract][Full Text] [Related]
2. Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease.
Marco-Contelles J; León R; de Los Ríos C; Guglietta A; Terencio J; López MG; García AG; Villarroya M
J Med Chem; 2006 Dec; 49(26):7607-10. PubMed ID: 17181144
[TBL] [Abstract][Full Text] [Related]
3. New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties.
León R; de los Ríos C; Marco-Contelles J; Huertas O; Barril X; Luque FJ; López MG; García AG; Villarroya M
Bioorg Med Chem; 2008 Aug; 16(16):7759-69. PubMed ID: 18640842
[TBL] [Abstract][Full Text] [Related]
4. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetylcholinesterase inhibitors.
Dorronsoro I; Alonso D; Castro A; del Monte M; García-Palomero E; Martínez A
Arch Pharm (Weinheim); 2005 Jan; 338(1):18-23. PubMed ID: 15674800
[TBL] [Abstract][Full Text] [Related]
6. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.
Samadi A; Marco-Contelles J; Soriano E; Alvarez-Pérez M; Chioua M; Romero A; González-Lafuente L; Gandía L; Roda JM; López MG; Villarroya M; García AG; Ríos Cde L
Bioorg Med Chem; 2010 Aug; 18(16):5861-72. PubMed ID: 20656495
[TBL] [Abstract][Full Text] [Related]
7. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues.
León R; Marco-Contelles J; García AG; Villarroya M
Bioorg Med Chem; 2005 Feb; 13(4):1167-75. PubMed ID: 15670925
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines.
Maalej E; Chabchoub F; Samadi A; de los Ríos C; Perona A; Morreale A; Marco-Contelles J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2384-8. PubMed ID: 21411323
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.
Samadi A; Valderas C; de los Ríos C; Bastida A; Chioua M; González-Lafuente L; Colmena I; Gandía L; Romero A; Del Barrio L; Martín-de-Saavedra MD; López MG; Villarroya M; Marco-Contelles J
Bioorg Med Chem; 2011 Jan; 19(1):122-33. PubMed ID: 21163662
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.
Chao X; He X; Yang Y; Zhou X; Jin M; Liu S; Cheng Z; Liu P; Wang Y; Yu J; Tan Y; Huang Y; Qin J; Rapposelli S; Pi R
Bioorg Med Chem Lett; 2012 Oct; 22(20):6498-502. PubMed ID: 22981331
[TBL] [Abstract][Full Text] [Related]
15. Rational approach to discover multipotent anti-Alzheimer drugs.
Rosini M; Andrisano V; Bartolini M; Bolognesi ML; Hrelia P; Minarini A; Tarozzi A; Melchiorre C
J Med Chem; 2005 Jan; 48(2):360-3. PubMed ID: 15658850
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.
de Los Ríos C; Egea J; Marco-Contelles J; León R; Samadi A; Iriepa I; Moraleda I; Gálvez E; García AG; López MG; Villarroya M; Romero A
J Med Chem; 2010 Jul; 53(14):5129-43. PubMed ID: 20575555
[TBL] [Abstract][Full Text] [Related]
17. Nontoxic and neuroprotective β-naphthotacrines for Alzheimer's disease.
Esquivias-Pérez M; Maalej E; Romero A; Chabchoub F; Samadi A; Marco-Contelles J; Oset-Gasque MJ
Chem Res Toxicol; 2013 Jun; 26(6):986-92. PubMed ID: 23676090
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.
Luo W; Li YP; He Y; Huang SL; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Jan; 19(2):763-70. PubMed ID: 21211982
[TBL] [Abstract][Full Text] [Related]
20. Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca²⁺ overload.
Wang Y; Wang F; Yu JP; Jiang FC; Guan XL; Wang CM; Li L; Cao H; Li MX; Chen JG
Bioorg Med Chem; 2012 Nov; 20(21):6513-22. PubMed ID: 23000296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]